These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 183644)
61. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity. Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896 [TBL] [Abstract][Full Text] [Related]
62. Equine herpesviruses. I. Isolation and characterisation of equine rhinopneumonitis virus and other equine herpesviruses from horses. Studdert MJ; Turner AJ; Peterson JE Aust Vet J; 1970 Mar; 46(3):83-9. PubMed ID: 4317854 [No Abstract] [Full Text] [Related]
63. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140 [TBL] [Abstract][Full Text] [Related]
64. Cytokine responses to EHV-1 infection in immune and non-immune ponies. Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413 [TBL] [Abstract][Full Text] [Related]
65. An outbreak of paresis in mares and geldings associated with equid herpesvirus 1. Crowhurst FA; Dickinson G; Burrows R Vet Rec; 1981 Dec; 109(24):527-8. PubMed ID: 6280366 [TBL] [Abstract][Full Text] [Related]
66. Prevention of respiratory infections with alpha- and gamma-herpesviruses in weanling foals by using a modified live intra-nasal equine influenza vaccine. Salco R; Bowers J; Hernandez V; Barnum S; Pusterla N Can Vet J; 2020 May; 61(5):517-520. PubMed ID: 32355351 [TBL] [Abstract][Full Text] [Related]
67. Impact of equine herpesvirus type 1 (EHV-1) infection on the migration of monocytic cells through equine nasal mucosa. Baghi HB; Nauwynck HJ Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):321-9. PubMed ID: 25456193 [TBL] [Abstract][Full Text] [Related]
68. Epidemiological investigation of equid herpesvirus-4 (EHV-4) excretion assessed by nasal swabs taken from thoroughbred foals. Gilkerson J; Jorm LR; Love DN; Lawrence GL; Whalley JM Vet Microbiol; 1994 Apr; 39(3-4):275-83. PubMed ID: 8042275 [TBL] [Abstract][Full Text] [Related]
69. Comparison of four methods to quantify Equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses. Pusterla N; Hussey SB; Mapes S; Leutenegger CM; Madigan JE; Ferraro GL; Wilson WD; Lunn DP J Vet Diagn Invest; 2009 Nov; 21(6):836-40. PubMed ID: 19901285 [TBL] [Abstract][Full Text] [Related]
70. Equid herpesvirus 2-associated oral and esophageal ulceration in a foal. Vengust M; Baird JD; van Dreumel T; Ackerley C; Bienzle D J Vet Diagn Invest; 2008 Nov; 20(6):811-5. PubMed ID: 18987236 [TBL] [Abstract][Full Text] [Related]
71. EHV1 and equine paresis. Mumford JA; Edington N Vet Rec; 1980 Mar; 106(12):277. PubMed ID: 6246670 [No Abstract] [Full Text] [Related]
72. Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. McCartan CG; Russell MM; Wood JL; Mumford JA Vet Rec; 1995 Jan; 136(1):7-12. PubMed ID: 7900264 [TBL] [Abstract][Full Text] [Related]
73. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. Burrows R; Goodridge D; Denyer MS Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728 [TBL] [Abstract][Full Text] [Related]
74. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR. Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902 [TBL] [Abstract][Full Text] [Related]
76. Monitoring and detection of acute viral respiratory tract disease in horses. Mumford EL; Traub-Dargatz JL; Salman MD; Collins JK; Getzy DM; Carman J J Am Vet Med Assoc; 1998 Aug; 213(3):385-90. PubMed ID: 9702229 [TBL] [Abstract][Full Text] [Related]
77. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730 [TBL] [Abstract][Full Text] [Related]
78. Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA. Studdert MJ; Hartley CA; Dynon K; Sandy JR; Slocombe RF; Charles JA; Milne ME; Clarke AF; El-Hage C Vet Rec; 2003 Oct; 153(14):417-23. PubMed ID: 14582730 [TBL] [Abstract][Full Text] [Related]
79. Seroprevalence of equine herpesvirus 1 in mares and foals on a large Hunter Valley stud farm in years pre- and postvaccination. Foote CE; Gilkerson JR; Whalley JM; Love DN Aust Vet J; 2003 May; 81(5):283-8. PubMed ID: 15084039 [TBL] [Abstract][Full Text] [Related]
80. Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs. Poelaert KCK; Van Cleemput J; Laval K; Favoreel HW; Couck L; Van den Broeck W; Azab W; Nauwynck HJ J Virol; 2019 Apr; 93(7):. PubMed ID: 30651370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]